Citadel Advisors - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$75,070
-76.1%
83,700
-68.5%
0.00%
Q4 2022$313,620
-77.1%
265,780
+45.9%
0.00%
Q3 2022$1,371,000
+291.7%
182,188
+227.7%
0.00%
Q2 2022$350,000
-32.0%
55,600
-10.3%
0.00%
Q1 2022$515,000
-16.7%
62,000
-47.9%
0.00%
Q4 2021$618,000
+19.5%
119,109
+54.1%
0.00%
Q3 2021$517,000
+53.9%
77,277
+96.1%
0.00%
Q2 2021$336,000
-96.0%
39,400
-95.8%
0.00%
-100.0%
Q1 2021$8,353,000
-35.8%
943,849
-10.8%
0.00%
-33.3%
Q4 2020$13,009,000
+64.1%
1,058,502
+8.7%
0.00%
+50.0%
Q3 2020$7,928,000
-6.5%
973,905
+10.3%
0.00%
-33.3%
Q2 2020$8,480,000
+46.2%
883,300
+3.5%
0.00%0.0%
Q1 2020$5,802,000
-10.6%
853,282
+96.0%
0.00%0.0%
Q4 2019$6,487,000
+47.2%
435,353
+1.3%
0.00%
+50.0%
Q3 2019$4,407,000
+39.1%
429,924
+43.9%
0.00%
+100.0%
Q2 2019$3,168,000298,8280.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 135,848$2,024,0006.74%
INTERWEST VENTURE MANAGEMENT CO 764,918$11,397,0004.91%
Knoll Capital Management, LLC 350,238$5,219,0003.85%
683 Capital Management, LLC 1,850,000$27,565,0003.15%
Soleus Capital Management, L.P. 205,407$3,060,0002.95%
Broadfin Capital, LLC 1,236,368$18,422,0002.47%
P.A.W. CAPITAL CORP 144,000$2,146,0002.29%
MANGROVE PARTNERS IM, LLC 847,284$12,625,0001.85%
Corriente Advisors, LLC 203,898$3,038,0001.63%
Trellus Management Company, LLC 63,850$951,0001.59%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders